Innovators of Genomic Immunology
Innovators of Genomic Immunology
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab Genomics91 - 105 of 328 Results Clear All
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab GenomicsNIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.
Gladstone Experts COVID-19 Virology Doudna Lab Ott LabBioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.
Gladstone Experts Alzheimer’s Disease Neurological Disease Huang LabABC News—Traumatic brain injuries can result in sleep disruptions and seizures. Gladstone Associate Investigator Jeanne Paz describes her team’s recent identification of an immune molecule that may be key to these symptoms, and the potential to treat brain injury survivors with new therapies.
Gladstone Experts Traumatic Brain Injury Neurological Disease Paz LabNautilus—In the ongoing war on cancer, some scientists are taking a new approach—turning on the body’s own self defense system. Assistant Investigator Karin Pelka describes her team’s efforts to train the immune system to recognize and fight tumors.
Gladstone Experts Genomic Immunology Pelka LabScientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.
Gladstone Experts COVID-19 Cardiovascular Disease Conklin LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on a potentially new type of COVID-19 vaccine that would fight the virus at its points of entry—the nose, throat, or lungs—and may provide even better protection than current shots in the arm.
Gladstone Experts COVID-19 Virology Roan LabSan Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, puts the CDC's definition of "fully vaccinated" in the context of our constantly evolving understanding of the COVID-19 pandemic.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene LabSan Francisco Chronicle—Associate Investigator Nadia Roan, PhD, explains that people who receive COVID-19 vaccination after having had the disease harbor special immune cells that may provide stronger and more durable protection against future infections.
Gladstone Experts COVID-19 Virology Roan LabUSA Today—Senior investigator Warner Greene, MD, PhD, comments on the benefits of vaccination after COVID-19 illness.
Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene LabABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava LabSan Francisco Business Times—Senior Investigator Katerina Akassoglou, PhD, was picked by the San Francisco Business Times as one of the most influential women in business in the Bay Area this year.
Gladstone Experts Center for Neurovascular Brain Immunology Akassoglou Lab DiversityKALW—Gladstone President Deepak Srivastava, MD, is one of two Bay Area leaders in COVID-19 research discussing current progress in the development of novel treatment, prevention and detection methods, at Gladstone and in the Bay Area.
Gladstone Experts COVID-19 Cardiovascular DiseaseSmithsonian Magazine—Associate Investigator Jeanne Paz, PhD, discusses her lab's recent discovery that C1q, a component of the immune system, mediates cognitive deficits after a traumatic brain injury and may lead to new ways to curb or prevent these deficits.
Gladstone Experts Traumatic Brain Injury Epilepsy Neurological Disease Paz LabGladstone experts discuss waning immunity against COVID-19 and whether you'll need a booster shot
Gladstone Experts COVID-19